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REPRODUCIBILITY OF ISCHEMIC INDICES ON EXERCISE TESTING 
AND ON HDLTER WNITORING IN CORONARY PATIENTS 
Jesaia Benhorin. m, Dan Trivoni, M.D., F.A.C-Co, Aharon 
kdina, ILD., Hady Horiel, M.D., Shulamit Botvin, M.D., 
Avraham Zilberman, M.D., Alex Gavish, M.D., and Shlomo 
Stern, H.D., F.A.C.C., Bikur Cholim Hospital, Israel. 
In order to determine the reproducibility of ischemic 
indices measured during treadmill testing {ZTT) and during 
ambulatory Holter monitoring, we performed a Bruce 
protocol ETT and a 72 hour Holter twice, 2 weeks apart, in 
41 pts with typical effort angina, positive ETT, and a 24 
hour Holter with 2 2 ischemic episodes. Mean age was 61 
years, 17 (42%) had a remote prior infarction, 18 (44%) 
were on beta blockers and none on calcium blockers. 
Results (meanisd): 
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?if ST& (INII) 3.6z1.5 3.6:l.g .85 
Kation (set) 423il31 434i120 .75 
Time to ST9 (set) 254&114 266i121 .51 
HR at 1 mm ST& (b/min) 112215 112&18 .81 
Max ST& (INII) 2.7iO.8 2.650.9 .62 
HR-heart rate: r=Pearson correlation coefficient. 
&g&l~&~: Indices of ischemia severity as measured by 
72 hour Halter and Bruce orotocol ETT are highly __ ..-- 
reproducible within 2 weeks, in stable coronary-pts who 
are known to be positive for ischemia on both tests. Thus, 
these testing procedures can be used to objectively assess 
treatment efficacy. 
DOES 3-CHANNEL 
MONITORING IMPRU’JE 
AMBULATORY 
DETECTION OF 
ELECTROCARDIOGRAPHIC 
ISCHEMIA? 
gldr~anH.. m, Susan M. Switzenberg, 
LaVergne A. Thomas, BA, Myrvin H. Ellestad, MD, FACC, 
Stephen B. Bernstein, MD, FACC. Memorial Heart 
Institute, Long Be”ach, CA. 
The recognition of silent ischemia (SI) has been 
demonstrated to have important clinical relevance. 
Two channel ambulatory electrocardiographic monitoring 
(AM) is a commonly utilized method for detecting SI. 
It has been suggested that analysis of 2 channels 
alone may not adequately detect SI. We therefore 
evaluated the diagnostic sensitivity of 3 channels 
using a newly developed 3-channel A!4 device in 45 
consecutive patients (age 62 f 9 yrs) undergoing 
percutaneous transluminal coronary angioplasty of an 
isolated single vessel stenosis. Various combinations 
of 2 lead recordings were cecnpared to all 3, ,lnd an 
absolute ST segment shift (STSS) of 2 lmm (luring 
balloon inflation was considered positive for 
ischemia. The number of patients testing posi.cive is 
detailed below under various lead groupings. 
Basults: 
Vessel 
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CIRC 5 3 3 3 -3 
RCA 17 11 10 11 10 
A total of 33 of 45 patients had STSS in all 3 leads 
(sensitivity - 73%), while 32 had STSS in the most 
sensitive 2 lead grouping (V2/V5), with sensitivity 
equal to 71%. (p - ns). 
!&D&d&D: 3-channel AM only marginally improves 
detection of ischemia when compared to standard (V2/V5 
or VS/AVF) 2-channel AM. 
Diastolic pressure-time index/systolic pressure-time 
index ratio (DPTI/SPTI) was found to be a reliable index 
of subendocardial oxygen supply/demand ratio. 
To assess the relative contributions of subendocardial 
ischemia and LV hypertrophy and function to the “strain” 
pattern of repolarization (StR) on the rest ECG in Pts 
with severe, pure, chronic aortic regurgitation (AR), we 
evaluated the DPTI/SPTI and LV angiographic findings in 53 
Pts with or without StR and normal coronary arteries. 
The 36 Pts with StR at ECG showed: greater age (56210 vs 
40212 years2 p<O.OOl), greater* LV end-diastolic (154+46 vs 
120222 ml/m , p<O.OOl) and end-systolic (80240 vs 52230 
ml/ JJ , ~~0.02) volumes, greater LV mass (168248 vs 140+44 
g/m , p<O.O5), higher LVEDP (22211 vs 15&10 mmHg,2pc0.02), 
higher LV peak meridian (217268 vs 153+92 Kdyn/$m , p<O.Ol) 
and circumferential (358+110 vs 259+153 Kdyn/cm , ptO.OO1) 
wall stresses. 
DPTI/SPTI was similar in the two groups (0.7kO.3 ws O.‘i+ 
0.4, NS) and higher than the critical value (about 0.4 to 
0.5) below which subendocardial ischemia may occur. 
Multiple linear regression analysis selected age (p<O.OOl) 
end-systolic volume (p= 0.0149) and circumferential wall 
stress (p= 0.0369) as factors independently related to StR. 
Thus, the StR on resting EGG in AR seems to be related 
to LV dysfunction and long-standing volume overload rather 
than to represent a marker of subendocardial ischemia. 
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APOLIPOPROTESN Al AND CORONARY DISEASE PROGRESSION: 
A S-YEAR ANGIOGRAPHIC STUDY 
Mark WI Webster MBChB. James H Chesebro,MD FACC, Bruce A 
Kottke, MD FACC, Hugh C Smith, MD FACC, Robert IL Frye, MD FACC, 
David R Holmes MD FACC, Guy S Reeder, MD FACC, Dennis R 
Bresnahan, MD FACC, Rick A Nishimura, MD FACC, Ian P Clements, 
MD FACC, William T Bardsley, MD FACC, Diane E Grill, MS, Kent R 
Bailey, PhD, Valentin Fuster, MD FACC, Mayo Clinic, Rochester, MN. 
Plasma apolipoproteins (APO) Al, All, and E may predict 
progression in patients with coronary artety disease (CAD). These 
were measured in a prospective study of 165 patients, all of whom 
underwent angiography on 2 occasions, 5.1 t 0.4 (SD) years apart. 
The patient population was a subset of 370 low risk, medically seated 
patients with CAD enrolled in a randomized trial of antiplatelet 
therapy. Angiograms were reviewed blindly by 2 panels of 2 
angiographers, with discrepancies resolved by a third panel. Patients 
were divided using Brensike criteria into those with disease progression 
(definite or probable progression without regression, or mixed 
progression/regression if more lesions progressed than regressed) and 
those with no change or disease regression (the remainder). 
Two thirds (110 patients) showed disease progression in one or 
more lesions. Separate logistic regressions were used to relate total 
cholesterol and Apo Al, AII, and E to the presence or absence of 
progression. Apo AI levels did not correlate with the number of 
lesions on the first angiogram (r=-0.07), but did predict subsequent 
lack of disease progression @=0.03), as did the Apo AI/E ratio 
@=0.03). Apo E levels tended to be positively associated with disease 
progression @=0.12). Total cholesterol, cholesterol and Apo 
AI1 were not predictive @=0.26, p=O.l =0.62 respectively). 
40 Al levels were positively correlated with Apo Al1 levels (r=O.48). 
APO AI, the major protein component of high density lipoprotein 
cholesterol, is inversely related to CAD progression and is a better 
predictor of progression than total cholesterol. 
